Novo Nordisk has launched a comprehensive patient support program, NovoSecure, for people with hemophilia. Eligible patients can apply for assistance including career counseling and HeroPath life coaching, which are specifically tailored to help patients address the often overlooked aspects of living with a chronic disease.
NovoSecure was created as a result of information obtained through Novo Nordisk’s Hemophilia Experiences, Results, and Opportunities (HERO) initiative, the largest international study on the psychosocial impact of hemophilia on patients and their loved ones, according to the company. The HERO data highlighted the need by people with hemophilia for additional support on how to manage life transitions and interpersonal relationships. People living with the disease reported not only that hemophilia creates additional burdens and stress in their daily lives, but they also worry about how it will affect their futures.
Additionally, the data indicated that young adults living with bleeding disorders encounter additional psychosocial challenges in daily life, with more than seven out of 10 of 66 millennial respondents saying their disease had a negative impact on their careers.
“Novo Nordisk has a long history of providing comprehensive, meaningful resources to the bleeding disorders community,” said Eddie Williams, senior vice president, Biopharmaceuticals, Novo Nordisk Inc. “We recognize people living with hemophilia and other bleeding disorders need support that goes well beyond the medical aspects of the diseases, which is why we have chosen to expand our offerings in this area, both with HeroPath and the new Career Counseling program.”
Source: Novo Nordisk
